Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 33 for “"Preclinical evaluation"”.

  1. PRECLINICAL EVALUATION OF A NOVEL NFIX INHIBITOR FOR MUSCULAR DYSTROPHIES TREATMENT

    Le Distrofie Muscolari (DM) sono malattie eterogenee, caratterizzate da progressiva degenerazione muscolare che, nei casi più severi, causa dipendenza dalla sedia a rotelle e morte prematura per blocco respiratorio o disfunzione cardiaca. La migliore strategia terapeutica per le DM coinvolge …

    milano Repository record for PRECLINICAL EVALUATION OF A NOVEL NFIX INHIBITOR FOR MUSCULAR DYSTROPHIES TREATMENT (opens in a new tab)

  2. Preclinical Evaluation of 3D Printed Biomaterials for Repairing Critical-Size Bone Defects

    … implantation in rats. <br>5- *In-vivo* evaluation of the biomaterials’ ability to support bone healing in a critical-size bone defect (15 mm rabbit’s radius segmental defect). Results and conclusion: Our results show that Ad-MSCs were capable of differentiating towards the osteogenic …

    cambridge Repository record for Preclinical Evaluation of 3D Printed Biomaterials for Repairing Critical-Size Bone Defects (opens in a new tab)

  3. Preclinical evaluation of a vaccine against IL-17 mediated inflammatory diseases including psoriasis

    Psoriasis is a chronic autoimmune skin condition. Interleukin 17A (IL-17A) is a pro-inflammatory cytokine with a key role in the pathogenesis of this disease. Antibodies targeting IL-17A have shown superior efficacy compared with other psoriasis treatments, and long-term studies have demonstrated …

    dundee Repository record for Preclinical evaluation of a vaccine against IL-17 mediated inflammatory diseases including psoriasis (opens in a new tab)

  4. Preclinical Evaluation of Immunomodulatory Effects of Aurora Kinase Inhibition In Human Papillomavirus Positive Cancers

    … of alisertib, an Aurora Kinase A inhibitor using preclinical mouse tumor models of HPV+ cancers (mEER, TC-1, and C3.43). In vitro, alisertib treatment when compared to the vehicle control, reduced the level of phospho-Aurora Kinase A confirming the targeted activity. We observed morphological …

    uthsc Repository record for Preclinical Evaluation of Immunomodulatory Effects of Aurora Kinase Inhibition In Human Papillomavirus Positive Cancers (opens in a new tab)

  5. Preclinical Evaluation of a Novel Polysaccharide Hydrogel for Local Chemotherapy Delivery to Solid Tumors

    … clinical setting. This dissertation entails the preclinical evaluation of a novel polysaccharide hydrogel drug delivery system. The gel is designed to be injected intratumorally to deliver a chemotherapeutic agent, to protect a fragile chemotherapy agent from being degraded quickly in vivo, to …

    tenn-hsc Repository record for Preclinical Evaluation of a Novel Polysaccharide Hydrogel for Local Chemotherapy Delivery to Solid Tumors (opens in a new tab)

  6. Preclinical evaluation of a novel telomerase inhibitor in malignant cells of the hematopoietic system

    Telomerase represents an attractive target for a mechanism-based therapeutic approach because its activation has been associated with unlimited proliferation in most cancer cells. Recently, a non-nucleosidic small molecule inhibitor, BIBR1532, has been identified which is highly selective for the …

    freiburg-diss Repository record for Preclinical evaluation of a novel telomerase inhibitor in malignant cells of the hematopoietic system (opens in a new tab)

  7. Preclinical Evaluation Of Infrared Light Therapy In A Rat Model Of Neonatal Hypoxic-Ischemic Encephalopathy

    … of a rat model of neonatal HIE for use in the preclinical evaluation of infrared light therapy (IRL). Consistent with results from previous IRL efficacy studies using a rat model of adult global brain ischemia, IRL treatment attenuated cerebral injury resulting from hypoxia-ischemia in the …

    wayne-thes Repository record for Preclinical Evaluation Of Infrared Light Therapy In A Rat Model Of Neonatal Hypoxic-Ischemic Encephalopathy (opens in a new tab)

  8. Synthesis and preclinical evaluation of peptide receptor-targeted diagnostic and therapeutic radiopharmaceuticals for prostate cancer

    … of this dissertation explore the development and preclinical evaluation of a radiolabeled antagonist peptide conjugate (RM2 = DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2) that targets the bombesin receptor (BB2r) overexpressed in human prostate cancer. Two …

    missouri Repository record for Synthesis and preclinical evaluation of peptide receptor-targeted diagnostic and therapeutic radiopharmaceuticals for prostate cancer (opens in a new tab)

  9. DEVELOPMENT OF AN IN VIVO MULTITASKING BIOLUMINESCENT REPORTER GENE PLATFORM FOR THE PRECLINICAL EVALUATION OF RNA THERAPEUTICS

    … small chemical molecules, makes their preclinical evaluation particularly challenging. Consequently, there is an urgent need for innovative preclinical platforms capable of capturing their complex biological effects beyond conventional toxicity and efficacy endpoints. This PhD thesis is …

    milano Repository record for DEVELOPMENT OF AN IN VIVO MULTITASKING BIOLUMINESCENT REPORTER GENE PLATFORM FOR THE PRECLINICAL EVALUATION OF RNA THERAPEUTICS (opens in a new tab)

  10. Molecular Characterization of the Opioid Receptors: Design, Development, and Preclinical Evaluation of Salvinorin A-Based Molecular Probes.

    … chemistry through the design, development, and preclinical evaluation of a series of C(22)-fused heteroaromatic salvinorin A analogues. Our in vitro models include: opioid receptor competitive radioligand binding affinity and functional [35S]GTP[γS] binding activity assays; while our in vivo …

    mississippi Repository record for Molecular Characterization of the Opioid Receptors: Design, Development, and Preclinical Evaluation of Salvinorin A-Based Molecular Probes. (opens in a new tab)

  11. Preclinical evaluation of dissolvable microarray patches for allergy treatment: key factors governing in vitro and in silico assessment

    … in understanding the factors that influence preclinical performance. These gaps are particularly evident in in vitro and in silico studies, where the lack of predictive, MAP-specific translational models remains a major limitation. To address these limitations, this thesis aimed to enhance …

    cork Repository record for Preclinical evaluation of dissolvable microarray patches for allergy treatment: key factors governing in vitro and in silico assessment (opens in a new tab)

  12. Evaluation of allogeneic bone marrow-derived mesenchymal stem cells for use in equine joints: in vitro to preclinical evaluation

    … BMDMSCs. Following in vitro studies, two preclinical, in vivo studies were performed. In the first study, allogeneic and autologous BMDMSCs were administered into clinically normal, contralateral, metacarpophalangeal joints. No difference was detected in the clinical or cytological …

    colostate Repository record for Evaluation of allogeneic bone marrow-derived mesenchymal stem cells for use in equine joints: in vitro to preclinical evaluation (opens in a new tab)

  13. Preclinical Evaluation of Matrix Metalloproteinase Inhibitors and Protein Kinase C Activators in Cell and Mouse Models of Huntington’s Disease

    <p>Huntington’s disease (HD) is an incurable genetic neurological disorder that affects 1 in 10,000 people, with no treatment that can alter the course of the disease. Neural cell death in the striatum and the cortex results from the accumulation of toxic mutant huntingtin protein (mHTT) fragments. …

    dominican Repository record for Preclinical Evaluation of Matrix Metalloproteinase Inhibitors and Protein Kinase C Activators in Cell and Mouse Models of Huntington’s Disease (opens in a new tab)

  14. Preclinical evaluation of a novel AAV-GDF5 vector in a 6-OHDA model of Parkinson’s disease and evaluation of the effect of 6-OHDA on the expression of HDACs

    Neurotrophic factors have shown promising results as potential disease-altering treatment methods for Parkinson’s disease (PD). However, there are many risks associated with surgically accessing such deeply located regions of the brain as the striatum or substantia nigra. Directly administered …

    cork Repository record for Preclinical evaluation of a novel AAV-GDF5 vector in a 6-OHDA model of Parkinson’s disease and evaluation of the effect of 6-OHDA on the expression of HDACs (opens in a new tab)

  15. Semi-synthesis, synthesis and preclinical evaluation of sigma receptors ligands for the treatment of neuropathic pain [Semi-sintesi, sintesi e valutazione preclinica dei ligandi dei recettori sigma per il trattamento del dolore neuropatico]

    Il dolore neuropatico (NP) è una condizione cronica che colpisce il 7−10% della popolazione generale affetta da dolore cronico, un’alterazione dei segnali a livello del sistema nervoso periferico o centrale. La sua complessa fisiologia rende i trattamenti attuali inefficaci e spesso con di effetti …

    catania Repository record for Semi-synthesis, synthesis and preclinical evaluation of sigma receptors ligands for the treatment of neuropathic pain [Semi-sintesi, sintesi e valutazione preclinica dei ligandi dei recettori sigma per il trattamento del dolore neuropatico] (opens in a new tab)

Page 1 of 2